Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2019
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation BurdenRyma Benayed, Michael Offin, Kerry Mullaney, et al.
Urology|July 30, 2020
RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell TumorsDouglas A Mata, Soo-Ryum Yang, Donna C Ferguson, et al.
The Journal of Molecular Diagnostics : JMD|December 16, 2023
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell NeoplasmsYing Liu, Caleb Ho, Wayne Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2013
ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancerJustin F Gainor, Anna M Varghese, Sai-Hong Ignatius Ou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2023
Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 InactivationSoo-Ryum Yang, Erika Gedvilaite, Ryan Ptashkin, et al.
JCO Oncology Practice|June 18, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO GuidelineChristina M Lockwood, Hans J Messersmith, Annette S Kim, et al.
European Urology Oncology|August 2, 2024
Clinical, Imaging, and Technical Factors Associated with Successful Genomic Profiling of Bone Biopsy Tissue in Prostate CancerFourat Ridouani, H Alberto Vargas, Daniel J Holzwanger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung CancerAdam J Schoenfeld, Joseph M Chan, Daisuke Kubota, et al.
Urologic Oncology|April 15, 2017
Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomyDaniel M Tennenbaum, Brandon J Manley, Emily Zabor, et al.
The Journal of Molecular Diagnostics : JMD|May 17, 2025
Leveraging RNA from DNA Extraction Lysate to Rescue "Insufficient" Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor SpecimensMark D Ewalt, Sara E DiNapoli, Kerry Mullaney, et al.
Pageof 20